Close Menu
NEW YORK (GenomeWeb News) — An Ontario Superior Court of Justice has cleared the way for Luminex to acquire Tm Bioscience, Tm said yesterday.
 
Tm last week said that the deal could close within a day of the court’s favorable decision.
 
As GenomeWeb News reported in December, the deal would exchange one Tm share for every .06 share of Luminex. Luminex said at the time that would be roughly a 41.5 percent premium for Tm’s shareholders.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.